Ifp Advisors, Inc Edwards Lifesciences Corp Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ifp Advisors, Inc holds 4,887 shares of EW stock, worth $331,143. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,887

Previous 3,968 23.16%

Holding current value

$331,143

Previous $379,000 19.0%

% of portfolio

0.02%

Previous 0.02%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$84.3 - $94.31 $77,471 - $86,670	919 Added 23.16%	4,887 $451,000
Q1 2024 Jul 30, 2024	SELL	$72.54 - $95.56 $76,384 - $100,624	-1,053 Reduced 20.97%	3,968 $379,000
Q4 2023 Jan 09, 2024	BUY	$61.71 - $77.76 $34,125 - $43,001	553 Added 12.38%	5,021 $382,000
Q3 2023 Oct 12, 2023	SELL	$69.28 - $93.38 $32,700 - $44,075	-472 Reduced 9.55%	4,468 $309,000
Q2 2023 Aug 04, 2023	BUY	$81.41 - $94.33 $69,849 - $80,935	858 Added 21.02%	4,940 $465,000
Q1 2023 Apr 18, 2023	SELL	$74.26 - $84.51 $575,812 - $655,290	-7,754 Reduced 65.51%	4,082 $337,000
Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $49,107 - $62,869	-719 Reduced 5.73%	11,836 $1.69 Million
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $76,604 - $99,779	930 Added 8.0%	12,555 $1.79 Million
Q2 2022 Sep 06, 2022	BUY	$86.5 - $128.27 $1.01 Million - $1.49 Million	11,625 New	11,625 $1.65 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $1.01 Million - $1.49 Million	-11,625 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$101.96 - $128.34 $551,399 - $694,062	5,408 Added 86.99%	11,625 $1.37 Million
Q1 2022 Aug 08, 2022	BUY	$101.96 - $128.34 $267,645 - $336,892	2,625 Added 73.08%	6,217 $731,000
Q4 2021 Jan 12, 2022	SELL	$106.37 - $130.68 $6,594 - $8,102	-62 Reduced 1.7%	3,592 $466,000
Q3 2021 Oct 06, 2021	SELL	$102.91 - $122.75 $2,366 - $2,823	-23 Reduced 0.63%	3,654 $415,000
Q2 2021 Jul 13, 2021	SELL	$83.84 - $104.76 $1.2 Million - $1.5 Million	-14,341 Reduced 79.59%	3,677 $379,000
Q1 2021 Apr 30, 2021	BUY	$78.68 - $90.67 $490,491 - $565,236	6,234 Added 52.9%	18,018 $1.51 Million
Q4 2020 Jan 25, 2021	BUY	$71.69 - $91.23 $109,183 - $138,943	1,523 Added 14.84%	11,784 $1.07 Million
Q3 2020 Oct 29, 2020	BUY	$67.19 - $87.44 $42,800 - $55,699	637 Added 6.62%	10,261 $820,000
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $340,924 - $455,928	5,925 Added 160.18%	9,624 $648,000
Q1 2020 May 12, 2020	BUY	$52.41 - $81.0 $4,402 - $6,804	84 Added 2.32%	3,699 $741,000
Q4 2019 Jan 17, 2020	SELL	$71.7 - $82.09 $33,914 - $38,828	-473 Reduced 11.57%	3,615 $847,000
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $217,025 - $265,966	3,526 Added 627.4%	4,088 $889,000
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $180,305 - $241,148	-3,765 Reduced 87.01%	562 $108,000
Q4 2018 Jan 23, 2019	BUY	$46.41 - $56.94 $974 - $1,195	21 Added 0.49%	4,327 $220,000
Q3 2018 Oct 25, 2018	BUY	$45.7 - $58.03 $6,672 - $8,472	146 Added 3.51%	4,306 $0
Q2 2018 Aug 07, 2018	SELL	$42.45 - $51.3 $25,470 - $30,780	-600 Reduced 12.61%	4,160 $0
Q1 2018 Jun 03, 2019	BUY	$37.19 - $47.45 $12,049 - $15,373	324 Added 7.3%	4,760 $536,000
Q1 2018 May 09, 2018	SELL	$37.19 - $47.45 $12,049 - $15,373	-324 Reduced 6.81%	4,436 $0
Q4 2017 Jan 24, 2018	SELL	$33.79 - $39.39 $83,258 - $97,056	-2,464 Reduced 34.11%	4,760 $0
Q3 2017 Oct 30, 2017	BUY	$36.29 - $38.83 $17,709 - $18,949	488 Added 7.24%	7,224 $790,000
Q2 2017 Jun 03, 2019	BUY	N/A	447 Added 7.11%	6,736 $796,000
Q1 2017 Jun 03, 2019	SELL	N/A	-40 Reduced 0.63%	6,289 $592,000
Q4 2016 Jun 03, 2019	BUY	N/A	878 Added 16.11%	6,329 $593,000
Q2 2016 Jun 03, 2019	BUY	N/A	4,889 Added 869.93%	5,451 $544,000
Q1 2016 Jun 03, 2019	BUY	N/A	562	562 $108,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account